1 min read
STERIS Raises Adjusted FY2027 EPS Outlook to $11.35-$11.55
Second-quarter revenue rose 9% to $1.6 billion, with constant-currency organic revenue growth of 8%.

STERIS plc raised its fiscal 2027 adjusted diluted earnings-per-share outlook to $11.35-$11.55 while agreeing to acquire Xodus Medical, Inc.
Second-quarter as-reported revenue rose 9% to $1.6 billion. Constant-currency organic revenue grew 8%. STERIS included tariff refunds received so far this fiscal year among the factors behind its revised outlook.